The blood pressure and heart failure medication valsartan has been the subject of several recalls in 2018. Three separate recalls were announced by the U.S. Food and Drug Administration (FDA) from July through the end of September because of the presence of harmful impurities. Known carcinogens were found in several lots from multiple different pharmaceutical […]